Guerbet SA (FRA:4G8)

Market Cap	127.41M -48.9%
Revenue (ttm)	798.67M -6.2%
Net Income	-108.33M
EPS	-8.59
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	51
Open	9.55
Previous Close	9.38
Day's Range	9.55 - 9.55
52-Week Range	7.74 - 23.60
Beta	n/a
RSI	48.13
Earnings Date	Sep 15, 2026

About Guerbet

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconnected solution; and Artirem, a gadoteric acid. The company also provides OptiStar Elite, a dual head contrast delivery system with an ultrasonic motor; ...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1901
• Employees: 2,746
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4G8